| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 25,135 | 29,301 | ||
| Trade accounts receivable, net of allowance of 1,180 and 1,000 | 12,995 | 11,248 | ||
| Inventories, net of provision for obsolescence of 1,134 and 1,032 | 9,145 | 8,192 | ||
| Prepaid expenses and other current assets | 1,513 | 1,174 | ||
| Total current assets | 48,788 | 49,915 | ||
| Property and equipment, net of accumulated depreciation and amortization of 4,270 and 3,989 | 2,390 | 2,048 | ||
| Operating lease right-of-use assets | 4,342 | 4,464 | ||
| Finance lease right-of-use assets | 33 | 38 | ||
| Other assets | 1,812 | 1,723 | ||
| Total assets | 57,365 | 58,188 | ||
| Accounts payable | 3,220 | 2,893 | ||
| Accrued expenses and other current liabilities | 7,344 | 7,275 | ||
| Current portion of operating lease liabilities | 393 | 378 | ||
| Current portion of finance lease liabilities | 21 | 20 | ||
| Total current liabilities | 10,978 | 10,566 | ||
| Long-term debt, net of debt discounts and issuance costs | 34,607 | 34,365 | ||
| Long-term operating lease liabilities | 4,173 | 4,292 | ||
| Long-term finance lease liabilities | 18 | 23 | ||
| Long-term contract liabilities | 1,216 | 1,194 | ||
| Other liabilities | 293 | 292 | ||
| Total liabilities | 51,285 | 50,732 | ||
| Common stock, 0.001 par value 75,000,000 shares authorized 37,819,478 issued and outstanding as of september 30, 2025, and 37,793,886 issued and outstanding as of december 31, 2024 | 38 | 38 | ||
| Additional paid-in capital | 93,633 | 93,054 | ||
| Accumulated deficit | -87,823 | -85,839 | ||
| Total stockholders equity | 5,848 | 7,253 | ||
| Non-controlling interest | 232 | 203 | ||
| Total equity | 6,080 | 7,456 | ||
| Total liabilities and equity | 57,365 | 58,188 | ||
Apyx Medical Corp (APYX)
Apyx Medical Corp (APYX)